Influence of social determinants of health and substance use characteristics on persons who use drugs pursuit of care for hepatitis C virus infection
- PMID: 31202286
- PMCID: PMC10530640
- DOI: 10.1016/j.jsat.2019.04.009
Influence of social determinants of health and substance use characteristics on persons who use drugs pursuit of care for hepatitis C virus infection
Abstract
Background: Social determinants of health (SDOH), i.e., social, behavioral and environmental factors, are increasingly recognized for their important influence on health outcomes. Data are limited on the influence of SDOH, substance use characteristics, and their interactions on pursuit of hepatitis C virus (HCV) care among individuals with opioid use disorder (OUD). Linkage to HCV care remains low in this population despite high HCV prevalence and incidence.
Aims: To investigate the influence of SDOH, substance use factors, and their interactions on HCV treatment uptake among OUD patients in a methadone treatment program.
Methods: Information on patient demographics, SDOH, substance use characteristics, and co-morbid medical conditions were obtained from the paper and electronic medical records of OUD patients on methadone. We applied multiple correspondence analysis, k-means algorithm, and logistic regression with least absolute shrinkage and selection operator penalty to identify variables and clusters associated with pursuit of HCV care.
Results: Data from 161 patients (57% male, 60% Caucasian, mean age 45 years) were evaluated. Being employed, the absence of support systems, and a history of foster care were the strongest positive predictors of treatment pursuit. The use of crack/cocaine as the initial illicit substance, criminal activity without incarceration, and the absence of a family history of chemical dependency were the strongest negative predictors. We identified clusters among persons with OUD based upon their likelihood to pursue HCV management.
Conclusion: Utilizing data from the medical record, we were able to identify factors positively and negatively associated with linkage-to-care for HCV. We were also able to divide patients into clusters of factors associated with linkage-to-care for HCV. These results could be used to identify individuals with OUD based upon their readiness for HCV care.
Keywords: Communicable diseases; Hepatitis; Social determinants of health; Substance-related disorders; Therapeutics; Treatment adherence and compliance.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declarations of Interest: None
Figures


Similar articles
-
Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone.Clin Infect Dis. 2019 Jul 2;69(2):323-331. doi: 10.1093/cid/ciy899. Clin Infect Dis. 2019. PMID: 30329042
-
Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage.J Subst Use Addict Treat. 2024 Dec;167:209524. doi: 10.1016/j.josat.2024.209524. Epub 2024 Sep 26. J Subst Use Addict Treat. 2024. PMID: 39341602
-
Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.J Subst Abuse Treat. 2017 May;76:77-80. doi: 10.1016/j.jsat.2017.01.017. Epub 2017 Feb 2. J Subst Abuse Treat. 2017. PMID: 28162850
-
Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health.PLoS One. 2020 Jan 21;15(1):e0227968. doi: 10.1371/journal.pone.0227968. eCollection 2020. PLoS One. 2020. PMID: 31961908 Free PMC article.
-
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.PLoS Med. 2019 Dec 31;16(12):e1003002. doi: 10.1371/journal.pmed.1003002. eCollection 2019 Dec. PLoS Med. 2019. PMID: 31891578 Free PMC article.
Cited by
-
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions.Int J Drug Policy. 2021 Oct;96:103283. doi: 10.1016/j.drugpo.2021.103283. Epub 2021 May 18. Int J Drug Policy. 2021. PMID: 34020864 Free PMC article.
-
Hepatitis C Reinfection in People Who Inject Drugs in Resource-Limited Countries: A Systematic Review and Analysis.Int J Environ Res Public Health. 2020 Jul 9;17(14):4951. doi: 10.3390/ijerph17144951. Int J Environ Res Public Health. 2020. PMID: 32659974 Free PMC article.
-
The Rise of Prescription Digital Therapeutics in Behavioral Health.Adv Ther. 2022 Dec;39(12):5301-5306. doi: 10.1007/s12325-022-02320-0. Epub 2022 Oct 15. Adv Ther. 2022. PMID: 36242730 Free PMC article.
-
Neighborhood Vigilance in Terms of Abstinence Expectancies for Smoking and Severity of Problems When Quitting.Subst Use Misuse. 2024;59(10):1495-1502. doi: 10.1080/10826084.2024.2360092. Epub 2024 Jun 3. Subst Use Misuse. 2024. PMID: 38831539 Free PMC article.
-
Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study.BMC Public Health. 2024 Nov 14;24(1):3167. doi: 10.1186/s12889-024-20625-3. BMC Public Health. 2024. PMID: 39543579 Free PMC article.
References
-
- Artenie AA, Jutras-Aswad D, Roy É, Zang G, Bamvita JM, Lévesque A, & Bruneau J. (2015). Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement. Journal of Viral Hepatitis, 22, 792–799. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical